Additional tools are available to measure disease activity. These are used mainly in clinical trials to help evaluate disease progression as well as changes in specific symptoms, such as fatigue, strength, mobility, vision, cognition, and others.
Read News ArticleAuthor: Hoff Communications
The Importance of Long-Term Treatment for Multiple Sclerosis
At the present, approved treatments are only available for individuals with relapsing forms of multiple sclerosis (MS) – largely for those with RRMS. Research (including many clinical trials) is ongoing at a rigorous pace to find treatments that will also be effective for the progressive forms of MS. Fortunately, symptom-management strategies and comprehensive care plans with teams of doctors, nurses, and therapists, help to greatly improve the quality of life for individuals with MS – both with relapsing and progressive forms of MS.
Read News ArticleThe Future of Multiple Sclerosis Research and Treatments
Targets for multiple sclerosis (MS) treatments include the many components and functions of the immune system response. In general, treatments have been developed to block, reduce, or deplete those cells and other agents that promote inflammation and/or damage to the central nervous system (CNS).
Read News ArticleUnderstanding Depression and Multiple Sclerosis
This recorded patient education program features the research team of Johns Hopkins University presenting on depression and MS as well as updates on clinical trials and stem cell research. Presenters include Adam Kaplin, MD, PhD; Chitra Krishnan, MHS; and Michael Levy, MD, PhD.
Read News ArticleA Closer Look at The Importance of Treating and Managing MS Relapses
In this relaxed, conversational-style interview, Dr. Stephen Krieger provides valuable insights into understanding the signs and symptoms of an MS relapse, guidance on when to discuss the onset of a flare up with a neurologist, and a thorough explanation of the various treatment options including steroids and other medications.
Read News ArticleA Closer Look at Multiple Sclerosis Symptoms — Part 1
This program contains four segments. They are: Effective MS Symptom Management; Understanding Depression and MS; Learning About Involuntary Emotional Expression Disorder; and Managing Spasticity. Among the top MS experts featured in this video include MSAA’s Chief Medical Officer Dr. Jack Burks as well as MSAA’s Healthcare Advisory Council member Dr. Donald Barone.
Read News ArticleA Closer Look at Clinically Isolated Syndrome and MS
In this program, MSAA’s Chief Medical Officer Dr. Jack Burks discusses Clinically Isolated Syndrome (CIS), which is a relatively new term neurologists use to indicate the possible onset of multiple sclerosis. In his discussion, Dr. Burks explains the process of diagnosing and treating CIS and its relationship the common form of relapsing-remitting multiple sclerosis (RRMS).
Read News ArticleA Closer Look at The Value of MRIs
The use of magnetic resonance imaging (MRI) plays an important role in diagnosing multiple sclerosis, tracking disease progression, and evaluating the effectiveness of prescribed therapy. This three-part program features interviews with an MS patient describing her experience undergoing an MRI exam, a noted neurologist explaining the value of an MRI, and a representative of MSAA discussing the organization’s two MRI financial assistance programs.
Read News ArticleA Closer Look at Managing MS Fatigue
In this program, licensed clinical social worker Allison Shadday, who has multiple sclerosis, provides a clinical understanding of MS fatigue, discusses various treatment options, and offers personal insights and effective strategies for managing one of the most common symptoms of MS.
Read News Article